Charles River Laboratories | CRL - 贸易债权人

股票价格
166.97
每天变化
3.13 1.91%
每月一次
-3.21%
每年
42.84%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.4B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


贸易债权人 更改 日
Agilent USD 602M 32M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
Bio-Rad Laboratories USD 133.1M 4.1M 2026-03
Bruker USD 215.9M 31.5M 2025-12
Cardinal Health USD 37.83B 1.16B 2026-03
Charles River Laboratories USD 148.8M 20.82M 2025-12
Cigna USD 10.66B 1.31B 2025-12
Concord Medical Services Hldg CNY 112.19M 19.4M 2025-06
CVS Health USD 59.38B 1.56B 2025-12
Danaher USD 1.79B 54M 2026-03
Dentsply International USD 300M 32M 2025-12
Elevance Health USD 6.21B 10.88B 2026-03
Galapagos EUR 104.65M 4.02M 2025-12
Humana USD 6.53B 814M 2026-03
Illumina USD 240M 22M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Intrexon USD 4.85M 3.12M 2024-06
IQVIA Holdings USD 3.75B 201M 2025-12
Laboratory Of America USD 840.8M 172.3M 2025-12
Lonza CHF 471M 3M 2024-12
McKesson USD 60.68B 255M 2025-12
Merck EUR 2.11B 182M 2025-12
Mettler Toledo International USD 266.63M 19.22M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Quest Diagnostics USD 1.5B 100M 2026-03
Revvity USD 185.46M 9.66M 2025-12
Thermo Fisher Scientific USD 3.62B 502M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
UnitedHealth USD 77.37B 37.19B 2025-12
Veradigm USD 30.84M 18.23M 2022-12
Waters USD 103.78M 11.95M 2025-12
West Pharmaceutical Services USD 252.3M 1.4M 2026-03